We are pleased to announce that the Translational Breast Cancer Research (TBCR) has attained its first impact factor for the 2024 citation year: 1.4 (Figure 1).
Figure 1 Journal Impact Factor of TBCR
Translational Breast Cancer Research is an open-access, peer-reviewed journal focusing on translational research in breast cancer. As a quarterly published journal, the journal seeks to create a platform for researchers and clinicians by presenting pertinent investigations, discussing critical questions relevant to the entire field of breast cancer, and aiming to develop new perspectives for all those issues concerned with breast cancer. Translational Breast Cancer Research is indexed and covered by Web of Science [Emerging Sources Citation Index (ESCI)], PubMed/PubMed Central (PMC) and Scopus.
We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in cancer research to bring more exciting content to readers in the coming future.
Editorial Office
Translational Breast Cancer Research